标题
Immunotherapy for the Treatment of Breast Cancer
作者
关键词
Tumor antigen, Vaccine, Immunotherapy, Tumor immunology
出版物
Current Oncology Reports
Volume 17, Issue 2, Pages -
出版商
Springer Nature
发表日期
2015-02-12
DOI
10.1007/s11912-014-0426-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis
- (2014) Zheng-Xu Wang et al. CYTOTHERAPY
- Emerging immunotherapy strategies in breast cancer
- (2014) David B Page et al. Immunotherapy
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
- (2013) B. V. Sinn et al. ANNALS OF ONCOLOGY
- Response to HER-2 Pulsed DC1 Vaccines is Predicted by Both HER-2 and Estrogen Receptor Expression in DCIS
- (2013) Megan Fracol et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
- (2013) Dimitrios Balafoutas et al. BMC CANCER
- Myeloid-derived suppressor cells in breast cancer
- (2013) Joseph Markowitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- (2013) Cristina Iclozan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer
- (2013) Kim M. Hirshfield et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Use of Statins and the Risk of Death in Patients With Prostate Cancer
- (2013) Oriana Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Advances in targeting cell surface signalling molecules for immune modulation
- (2013) Sheng Yao et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study of circulating antibodies against CD25 and FOXP3 in breast cancer
- (2013) Tong Liu et al. TUMOR BIOLOGY
- Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial
- (2013) Nuhad K. Ibrahim et al. Journal of Cancer
- Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
- (2013) S. Kitano et al. Cancer Immunology Research
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer
- (2013) Ben C. Creelan et al. OncoImmunology
- Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
- (2013) Erika J Schneble et al. Journal for ImmunoTherapy of Cancer
- Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells
- (2012) Venkataswarup Tiriveedhi et al. BREAST CANCER RESEARCH AND TREATMENT
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
- (2012) Anupama Sharma et al. CANCER
- Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
- (2012) Leisha A Emens Expert Review of Anticancer Therapy
- Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells
- (2012) R. N. Ramos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The GP2 peptide: A HER2/neu-based breast cancer vaccine
- (2012) Kevin S. Clive et al. JOURNAL OF SURGICAL ONCOLOGY
- Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment
- (2012) Patricia Mucci LoRusso ONCOLOGY
- Carcinoembryonic Antigen (CEA)-Based Cancer Vaccines: Recent Patents and Antitumor Effects from Experimental Models to Clinical Trials
- (2012) Mario Turriziani et al. Recent Patents on Anti-Cancer Drug Discovery
- A signature of immune function genes associated with recurrence-free survival in breast cancer patients
- (2011) Maria Libera Ascierto et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of interleukin-10 in breast cancer
- (2011) Hamidullah et al. BREAST CANCER RESEARCH AND TREATMENT
- A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
- (2011) M. Mohebtash et al. CLINICAL CANCER RESEARCH
- AE37: a novel T-cell-eliciting vaccine for breast cancer
- (2011) Alan K Sears et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer
- (2011) Gary K. Koski et al. JOURNAL OF IMMUNOTHERAPY
- Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
- (2011) Soyoung Baek et al. Journal of Translational Medicine
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
- (2011) D. Miles et al. ONCOLOGIST
- Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy
- (2011) Ahmed Hamaï et al. PLoS One
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
- (2011) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
- (2010) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
- (2010) Chrystelle Brignone et al. Journal of Translational Medicine
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study
- (2010) Fang Xie et al. PATHOLOGY RESEARCH AND PRACTICE
- Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model
- (2009) S Julien et al. BRITISH JOURNAL OF CANCER
- Tumor Vaccines for Breast Cancer
- (2009) Karen S. Anderson CANCER INVESTIGATION
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
- (2009) A. Carpi et al. CURRENT CANCER DRUG TARGETS
- Rapamycin: could it enhance vaccine efficacy?
- (2009) Jae-Hwan Nam Expert Review of Vaccines
- Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
- (2009) Leisha A. Emens et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR regulates memory CD8 T-cell differentiation
- (2009) Koichi Araki et al. NATURE
- Optimal dose and schedule of an HER-2/neu(E75) peptide vaccine to prevent breast cancer recurrence
- (2008) Jarrod P. Holmes et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation